Hwa Jung Yook

Hwa Jung Yook

Auto-generated profile, based on publicly available information

Hwa Jung Yook

Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
JHJu Hee Han
Ju Hee Han
HLHyun Ji Lee
Hyun Ji Lee
HYHwa Jung Yook
Hwa Jung Yook
KHKyungdo Han
Kyungdo Han
JLJi Hyun Lee
Ji Hyun Lee
YPYoung Min Park
Young Min Park
Han JH, et al. Allergy Asthma Immunol Res. 2023 Jan;15(1):55-66. https://doi.org/10.4168/aair.2023.15.1.55

5 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HYHwa Jung Yook
Hwa Jung Yook
EKEsther Kim
Esther Kim
Yeong Ho KimYeong Ho Kim
Yeong Ho Kim
GLGyu-Na Lee
Gyu-Na Lee
KHKyungdo Han
Kyungdo Han
JLJi Hyun Lee
Ji Hyun Lee
Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by painful, recurrent abscesses and tunnels under the skin. It is influenced by a complex interplay of genetic, environmental, and metabolic factors. Smoking, diabetes mellitus, obesity, and other metabolic disorders have been identified as risk factors for HS, potentially exacerbating the severity and progression of the condition. Given the higher prevalence of HS in individuals with type 2 diabetes mellitus (T2DM), understanding modifiable risk factors such as smoking is crucial for improving patient outcomes. Objectives: To investigate the association between changes in smoking intensity and the risk of HS in patients with T2DM, with the goal of elucidating how smoking contributes to the development or worsening of HS in this high-risk population. Methods: This retrospective cohort study analyzed data from the Korean National Health Insurance Service, comprising 1,705,427 participants. The study examined smoking status, changes in smoking intensity, and the incidence of HS in individuals with T2DM, adjusting for potential confounders such as age, gender, and comorbid conditions. Results: The study found a 23.6% increased risk of HS in individuals who continued smoking compared to nonsmokers (adjusted hazard ratio (aHR), 1.236; 95% confidence interval (CI), 1.075–1.421). Additionally, participants with increased cigarette consumption had a 28.5% higher risk of HS compared to nonsmokers (aHR, 1.285; 95% CI, 1.048–1.577). However, no significant differences were observed in the association between changes in smoking intensity and the risk of HS when stratified by BMI. Conclusions: This study highlights the association between smoking and the increased risk of HS in individuals with T2DM, underscoring the importance of smoking cessation as a potential strategy for mitigating HS risk in at-risk DM populations. Additional research is needed to further explore the mechanisms by which smoking exacerbates HS in T2DM and to identify effective interventions for this group.

10 August 2023 in Lasers in Medical Science
Verified
Journal Article
Closed access
PDF file
Yeong Ho KimYeong Ho Kim
Yeong Ho Kim
YCYoung Sook Cheon
Young Sook Cheon
GJGa Hee Jeong
Ga Hee Jeong
HYHwa Jung Yook
Hwa Jung Yook
JHJu Hee Han
Ju Hee Han
YPYoung Min Park
Young Min Park

1 January 2023 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
JHJu Hee Han
Ju Hee Han
HYHwa Jung Yook
Hwa Jung Yook
CBChul Hwan Bang
Chul Hwan Bang
JLJi Hyun Lee
Ji Hyun Lee
YPYoung Min Park
Young Min Park
JLJun Young Lee
Jun Young Lee
Han JH, et al. Ann Dermatol. 2023 May;35:e62. https://doi.org/10.5021/ad.20.332

30 September 2020 in Korean Journal of Medical Mycology
Verified
Journal Article
Open access
JLJi Hyun Lee
Ji Hyun Lee
HYHwa Jung Yook
Hwa Jung Yook
In November 2019, the coronavirus disease-2019 (COVID-19) outbreak was first reported. The infection of COVID-19 has rapidly spread worldwide. Some have unapparent or mild symptoms, but some patients have fatal forms including respiratory or multiple organ failure. In March 2020, the World Health Organization announced COVID-19 as pandemic disease. The COVID-19 pandemic is a sudden, difficult-to-control, and severe disease that can also appear to patients in dermatology. However, understanding disease and experience with it is still insufficient. Therefore, we would like to review patients with fungal infections in the COVID-19 pandemic era.